Role of T198 modification in the regulation of p27Kip1 protein stability and function

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Schiappacassi, Monica ^a   Lovisa, Sara ^a   Lovat, Francesca ^a   Fabris, Linda ^a   Colombatti, Alfonso ^a   Belletti, Barbara ^a   Baldassarre, Gustavo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; STATHMIN; THREONINE; PROTEASOME;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; CELL MOTION; CHEMISTRY; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION; POINT MUTATION; PROTEIN PROCESSING; STRUCTURE ACTIVITY RELATION;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; HUMANS; MICE; PHOSPHORYLATION; POINT MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; STRUCTURE-ACTIVITY RELATIONSHIP; THREONINE;

EID: 79952681689     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017673     Document Type: Article

References (41)

1. Malumbres M, Barbacid M, (2001) To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231.
2. Belletti B, Nicoloso MS, Schiappacassi M, Chimienti E, Berton S, et al. (2005) p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs. Curr Med Chem 12: 1589-1605.
3. Medema RH, Kops GJ, Bos JL, Burgering BM, (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787.
4. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, et al. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-5.
5. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, et al. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3: 231-4.
6. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, et al. (1997) Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med 3: 227-30.
7. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, et al. (1999) Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 13: 1181-9.
8. Carrano AC, Eytan E, Hershko A, Pagano M, (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193-9.
9. Bloom J, Pagano M, (2003) Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 13: 41-7.
10. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, et al. (2001) A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 413: 323-7.
11. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H, (1999) p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 9: 661-4.
12. Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, et al. (2007) Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128: 269-80.
13. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, et al. (2007) p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128: 281-94.
14. Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, et al. (2004) Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol 6: 1229-35.
15. Miranda-Carboni GA, Krum SA, Yee K, Nava M, Deng QE, et al. (2008) A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors. Genes Dev 22: 3121-34.
16. Motti ML, De Marco C, Califano D, Fusco A, Viglietto G, (2004) Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer. Cell Cycle 3: 1074-80.
17. Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, et al. (2009) RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci U S A 106: 9268-73.
18. Kossatz U, Vervoorts J, Nickeleit I, Sundberg HA, Arthur JS, et al. (2006) C-terminal phosphorylation controls the stability and function of p27kip1. EMBO J 25: 5159-70.
19. Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, et al. (2005) p27Kip1-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7: 51-63.
20. Schiappacassi M, Lovat F, Canzonieri V, Belletti B, Berton S, et al. (2008) p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer Ther 7: 1164-75.
21. Berton S, Belletti B, Wolf K, Canzonieri V, Lovat F, et al. (2009) The tumor suppressor functions of p27kip1 include control of the mesenchymal/amoeboid transition. Mol Cell Biol 29: 5031-45.
22. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, et al. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22.
23. Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, et al. (2008) Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 19: 2003-13.
24. Belletti B, Pellizzari I, Berton S, Fabris L, Wolf K, et al. (2010) p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Mol Cell Biol 30: 2229-40.
25. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, et al. (2007) The energy sensing LKB1-AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9: 218-24.
26. Vlach J, Hennecke S, Amati B, (1997) Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 16: 5334-4.
27. Langenickel TH, Olive M, Boehm M, San H, Crook MF, et al. (2008) KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice. J Clin Invest 118: 3848-59.
28. Delaloy C, Liu L, Lee JA, Su H, Shen F, et al. (2010) MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell 6: 323-35.
29. Ridley AJ, (2006) Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16: 522-9.
30. Machacek M, Hodgson L, Welch C, Elliott H, Pertz O, et al. (2009) Coordination of Rho GTPase activities during cell protrusion. Nature 461: 99-103.
31. Woo S, Gomez TM, (2006) Rac1 and RhoA promote neurite outgrowth through formation and stabilization of growth cone point contacts. J Neurosci 26: 1418-28.
32. Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, et al. (2006) p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 20: 1511-24.
33. Kawauchi T, Chihama K, Nabeshima Y, Hoshino M, (2006) Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 8: 17-26.
34. Watabe-Uchida M, John KA, Janas JA, Newey SE, Van Aelst L, (2006) The Rac activator DOCK7 regulates neuronal polarity through local phosphorylation of stathmin/Op18. Neuron 51: 727-39.
35. Ozon S, Guichet A, Gavet O, Roth S, Sobel A, (2002) Drosophila stathmin: a microtubule-destabilizing factor involved in nervous system formation. Mol Biol Cell 13: 698-710.
36. Galea CA, Nourse A, Wang Y, Sivakolundu SG, Heller WT, et al. (2008) Role of intrinsic flexibility in signal transduction mediated by the cell cycle regulator, p27Kip1. J Mol Biol 376: 827-38.
37. Molatore S, Kiermaier E, Jung CB, Lee M, Pulz E, et al. (2010) Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors. Mol Cancer 9: 116.
38. Parcellier A, Brunet M, Schmitt E, Col E, Didelot C, et al. (2006) HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells. FASEB J 20: 1179-81.
39. Frost V, Al-Mehairi S, Sinclair AJ, Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27(KIP1) in transformed lymphoid cells. Oncogene 2001 May 17;20 (22): 2737-48.
40. Tang PP, Hsieh SC, Wang FF, Modulation of caspase activation and p27(Kip1) degradation in the p53-induced apoptosis in IW32 erythroleukemia cells. Cell Signal 2002 Nov;14 (11): 961-8.
41. Medina-Palazon C, Bernard E, Frost V, Morley S, Sinclair AJ, KIPase activity is a novel caspase-like activity associated with cell proliferation. Eur J Biochem 2004 Jul;271 (13): 2716-23.